Global BioAccess Fund - aVenture Asset Manager Research
Location
New York City, NY, US
Founded
2021
Global BioAccess Fund focuses on investing in transformative technologies that address serious unmet medical needs in oncology, rare disease, CNS, and cardiology. The firm primarily supports early-stage companies requiring capital for IND submission and clinical trials. Based in New York, Global BioAccess Fund typically participates in Series C funding rounds.
Notable portfolio companies include Odyssey Therapeutics, which has raised $101 million. The firm is led by key partners with significant expertise in the medical and biotech sectors. Global BioAccess Fund emphasizes a hands-on investment philosophy, providing strategic guidance and leveraging its extensive network to accelerate the growth of its portfolio companies.
Global BioAccess Fund - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies1
Current Portfolio Count1
Top Investment Stages
Series C1 (100.0%)
Stage Mix
Series C 100%
Concentration shown as share of disclosed investments by stage.